BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 29603279)

  • 21. Teduglutide in short bowel syndrome patients: A way back to normal life?
    Harpain F; Schlager L; Hütterer E; Dawoud C; Kirchnawy S; Stift J; Krotka P; Stift A
    JPEN J Parenter Enteral Nutr; 2022 Feb; 46(2):300-309. PubMed ID: 34614239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Teduglutide: a review of its use in the treatment of patients with short bowel syndrome.
    Burness CB; McCormack PL
    Drugs; 2013 Jun; 73(9):935-47. PubMed ID: 23729002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Outcomes With Teduglutide From a Single Center.
    Puello F; Wall E; Herlitz J; Lozano ES; Semrad C; Micic D
    JPEN J Parenter Enteral Nutr; 2021 Feb; 45(2):318-322. PubMed ID: 32391948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of teduglutide in adult patients with short bowel syndrome - a European socioeconomic perspective.
    Walter E; Dawoud C; Hütterer E; Stift A; Harpain F
    Am J Clin Nutr; 2024 May; 119(5):1187-1199. PubMed ID: 38431119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colon polyps in patients with short bowel syndrome before and after teduglutide: Post hoc analysis of the STEPS study series.
    Armstrong D; Forbes A; Jeppesen PB; Lee HM; Nagy P; Seidner DL
    Clin Nutr; 2020 Jun; 39(6):1774-1777. PubMed ID: 31522784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term treatment with teduglutide: a 48-week open-label single-center clinical trial in children with short bowel syndrome.
    Lambe C; Talbotec C; Kapel N; Barbot-Trystram L; Brabant S; Nader EA; Pigneur B; Payen E; Goulet O
    Am J Clin Nutr; 2023 Jun; 117(6):1152-1163. PubMed ID: 37270289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of teduglutide after 52 weeks of treatment in patients with short bowel intestinal failure.
    O'Keefe SJ; Jeppesen PB; Gilroy R; Pertkiewicz M; Allard JP; Messing B
    Clin Gastroenterol Hepatol; 2013 Jul; 11(7):815-23.e1-3. PubMed ID: 23333663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term clinical evaluation of teduglutide for patients with Crohn's disease on home parenteral support for postoperative short bowel syndrome with intestinal failure.
    Sato T; Uchino M; Takeuchi J; Fujihira Y; Shimizu K; Yokoyama K; Yagi S; Kaku K; Takashima Y; Ikenouchi M; Kojima K; Kawai M; Nagase K; Kamikozuru K; Yokoyama Y; Takagawa T; Ikeuchi H; Watanabe K; Shinzaki S
    Clin Nutr; 2023 May; 42(5):722-731. PubMed ID: 37001195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes from a 12-Week, Open-Label, Multicenter Clinical Trial of Teduglutide in Pediatric Short Bowel Syndrome.
    Carter BA; Cohran VC; Cole CR; Corkins MR; Dimmitt RA; Duggan C; Hill S; Horslen S; Lim JD; Mercer DF; Merritt RJ; Nichol PF; Sigurdsson L; Teitelbaum DH; Thompson J; Vanderpool C; Vaughan JF; Li B; Youssef NN; Venick RS; Kocoshis SA
    J Pediatr; 2017 Feb; 181():102-111.e5. PubMed ID: 27855998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of teduglutide effectiveness in parenteral nutrition-dependent short-bowel syndrome subjects.
    Vipperla K; O'Keefe SJ
    Expert Rev Gastroenterol Hepatol; 2013 Nov; 7(8):683-7. PubMed ID: 24134154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Teduglutide: A Review in Short Bowel Syndrome.
    Kim ES; Keam SJ
    Drugs; 2017 Mar; 77(3):345-352. PubMed ID: 28194723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of Teduglutide for Parenteral Support Reduction in Patients with Short Bowel Syndrome: A Systematic Review and Meta-Analysis.
    Bioletto F; D'Eusebio C; Merlo FD; Aimasso U; Ossola M; Pellegrini M; Ponzo V; Chiarotto A; De Francesco A; Ghigo E; Bo S
    Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients.
    Jeppesen PB; Sanguinetti EL; Buchman A; Howard L; Scolapio JS; Ziegler TR; Gregory J; Tappenden KA; Holst J; Mortensen PB
    Gut; 2005 Sep; 54(9):1224-31. PubMed ID: 16099790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy, safety, and pharmacokinetics of teduglutide in adult Japanese patients with short bowel syndrome and intestinal failure: two phase III studies with an extension.
    Nakamura S; Wada M; Mizushima T; Sugita A; Tazuke Y; Ohge H; Udagawa E; Suzuki RK; Yoon M; Grimm A; Chen ST; Ikeuchi H
    Surg Today; 2023 Mar; 53(3):347-359. PubMed ID: 36201060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term results of teduglutide treatment for chronic intestinal failure - Insights from a national, multi-centric patient home-care service program.
    Greif S; Maasberg S; Wehkamp J; Fusco S; Zopf Y; Herrmann HJ; Lamprecht G; Jacob T; Schiefke I; von Websky MW; Büttner J; Blüthner E; Tacke F; Pape UF
    Clin Nutr ESPEN; 2022 Oct; 51():222-230. PubMed ID: 36184208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in Parenteral Nutrition Requirements and BMI in Patients with Parenteral Nutrition-Dependent Short Bowel Syndrome after Stopping Teduglutide-9 Years of Follow-Up.
    Zaczek Z; Jurczak-Kobus P; Panczyk M; Braszczyńska-Sochacka J; Majewska K; Kunecki M; Dąbrowska K; Sobocki J
    Nutrients; 2022 Apr; 14(8):. PubMed ID: 35458196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Variable Response to Teduglutide in Pediatric Short Bowel Syndrome: A Single Country Real-Life Experience.
    Guz-Mark A; Hino B; Berkowitz D; Hartman C; Millman PN; Orlanski-Meyer E; Shaoul R; Spector-Cohen I; Weiss B; Zangen T; Shamir R
    J Pediatr Gastroenterol Nutr; 2022 Sep; 75(3):293-298. PubMed ID: 35730756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population pharmacokinetics and exposure-response analyses of teduglutide in adult and pediatric patients with short bowel syndrome.
    Marier JF; Jomphe C; Peyret T; Wang Y
    Clin Transl Sci; 2021 Nov; 14(6):2497-2509. PubMed ID: 34402197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Teduglutide enhances structural adaptation of the small intestinal mucosa in patients with short bowel syndrome.
    Tappenden KA; Edelman J; Joelsson B
    J Clin Gastroenterol; 2013 Aug; 47(7):602-7. PubMed ID: 23426461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Is there life after teduglutide?].
    Martínez Martínez AL; Calles Romero LA; Etxeberría Martín E; Monasterio Jiménez O; Zabalegui Eguinoa A; Paja Fano M; Monzón Mendiolea A; Cadenas González A; Cabriada Nuno JL; Iglesias Hernández NC
    Nutr Hosp; 2020 Jul; 34(3):631-635. PubMed ID: 32406744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.